Interplay of procoagulatory and neutrophil-derived anticoagulatory proteins in C1q-NET–driven blood coagulation

M Minnah Thomas (Regeneron Pharmaceuticals Inc, Tarrytown, NY) D Davor Frleta (Regeneron Pharmaceuticals Inc, Tarrytown, NY) K KehDih Lai (Regeneron pharmaceuticals, Tarrytown, New York, United States) J John O’Brien (College of Optometry, University of Houston) A Aditi K. Patel (Regeneron Pharmaceuticals Inc, Tarrytown, NY) Y Yuanqi Zhao (Regeneron Pharmaceuticals Inc, Tarrytown, NY) K Keith A. Kobylarz (Regeneron Pharmaceuticals Inc, Tarrytown, NY) N Naxin Tu (Regeneron Pharmaceuticals Inc, Tarrytown, NY) G Gabor Halasz C Chunguang Guo (Regeneron Pharmaceuticals Inc, Tarrytown, NY) L Lynn E. Macdonald (Regeneron Pharmaceuticals Inc. Tarrytown) L Lori G. Morton (Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States) D Dan Chalothorn (Regeneron Pharmaceuticals, Inc., New York, New York, United States) K Kishor B. Devalaraja-Narashimha (Regeneron Pharmaceuticals Inc, Tarrytown, NY)

Abstract

Abstract Neutrophils interact with the external milieu in both tissue and blood microenvironments and are emerging as important regulators of blood coagulation. In this study, we explored whether complement induces neutrophil extracellular trap (NET) formation and related blood coagulation using human donor-derived neutrophils. Complement C1q induces NETosis in lipopolysaccharide (LPS) O127–primed neutrophils, whereas LPS alone does not induce NETosis. Bulk RNA sequencing revealed a unique LPS-driven altered neutrophil state, and complement sensitivity for NETosis was found to be transcriptionally dependent. Using an arrayed CRISPR knockout screen in the neutrophil-like differentiated HL60 cells, we identified that SCARF1 and complement receptor 3 are required for C1q-NETosis. Given NETs contain procoagulatory components such as DNA and histones, we investigated whether C1q-related NETs influenced blood coagulation. LPS+C1q-NETs were associated with reduced coagulation activity compared with LPS treatment alone. We further found that LPS upregulated tissue factor expression and coagulation-related activity in neutrophils. Furthermore, neutrophils secrete anticoagulant proteins, including protein C and tissue factor pathway inhibitors, during C1q-mediated NET formation that functionally regulate NET-related coagulation. C1q-NETs also activate the coagulation factors XII and XI, facilitating both intrinsic coagulation and kallikrein-dependent bradykinin production. This study elucidates how NETs regulate both procoagulatory and anticoagulatory components that may influence the pathophysiology of disease.

Article Details

Journal Blood
Volume / Issue Vol. 146, Issue 24
Published December 11, 2025
Pages 2993-3002
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (14)

M

Minnah Thomas

Regeneron Pharmaceuticals Inc, Tarrytown, NY

D

Davor Frleta

Regeneron Pharmaceuticals Inc, Tarrytown, NY

K

KehDih Lai

Regeneron pharmaceuticals, Tarrytown, New York, United States

J

John O’Brien

College of Optometry, University of Houston

A

Aditi K. Patel

Regeneron Pharmaceuticals Inc, Tarrytown, NY

Y

Yuanqi Zhao

Regeneron Pharmaceuticals Inc, Tarrytown, NY

K

Keith A. Kobylarz

Regeneron Pharmaceuticals Inc, Tarrytown, NY

N

Naxin Tu

Regeneron Pharmaceuticals Inc, Tarrytown, NY

G

Gabor Halasz

C

Chunguang Guo

Regeneron Pharmaceuticals Inc, Tarrytown, NY

L

Lynn E. Macdonald

Regeneron Pharmaceuticals Inc. Tarrytown

L

Lori G. Morton

Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States

D

Dan Chalothorn

Regeneron Pharmaceuticals, Inc., New York, New York, United States

K

Kishor B. Devalaraja-Narashimha

Regeneron Pharmaceuticals Inc, Tarrytown, NY